$150.27
▼ -2.7% Today
as of Oct 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Belite Bio Moves Listing to Nasdaq Global Select Market
Belite Bio Announces Uplisting to the Nasdaq Global Select Market
Belite Bio Stock In Focus After Stargardt Drug Filings In Three Markets
BLTE earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.2% on average; after the most recent report on May 20, 2026 it moved +2.6%. BLTE beat the consensus EPS estimate in 1 of its last 4 reported quarters. The share price of $150.27 sits in the middle of its 52-week range.
Overview
52-week range
$89
$200
55% of range
Avg surprise (last 4)
-2.7%
Avg reaction (last 2)
+0.4%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 20, 2026 | Mar/2026 | $-0.34 | $-0.60 | +43.3% | +24.4% | +2.6% | earnings |
| Mon Nov 10, 2025 | Sep/2025 | $-0.65 | $-0.53 | -22.6% | — | — | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.50 | $-0.47 | -6.4% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.45 | $-0.36 | -25.0% | — | -1.8% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for BLTE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ALKS
Alkermes plc
$7.0B
$44.18+0.2%
KNSA
Kiniksa Pharmaceuticals International, plc
$6.1B
$80.79-2.9%
LGND
Ligand Pharmaceuticals Incorporated
$5.8B
$307.82+0.5%
IONS
Ionis Pharmaceuticals, Inc.
$7.3B
$43.91-3.3%
PTCT
PTC Therapeutics, Inc.
$5.3B
$63.04+0.2%
COGT
Cogent Biosciences, Inc.
$5.2B
$31.31+0.2%
BLTE earnings FAQ
How does BLTE stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.2%, up 1 times and down 1 times.